Transcriptomics

Dataset Information

0

Expression profile of osteoclasts treated with bisphosphonates


ABSTRACT: Bisphosphonates are the mainstay of therapy worldwide for osteoporosis. They inhibit the activities of the osteoclasts, the bone resorption cells. While bisphosphonates are known to block farnesyl pyrophsophate synthase to exert their anti-resorptive action, the detailed mechanism is not well understood. Examining the change in expression profile before and after bisphosphonate treatment in the osteoclasts might shed some light on the biological pathways that are perturbed. Osteoclastic precursor cells were treated with (or without) bisphosphonates (alendronate or risedronate) during their differentiation into mature osteoclasts.

ORGANISM(S): Homo sapiens  

SUBMITTER: Tony Yuen   

PROVIDER: E-GEOD-63009 | ArrayExpress | 2014-11-06

SECONDARY ACCESSION(S): GSE63009PRJNA266418

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

2010-03-22 | E-GEOD-20850 | ArrayExpress
2014-10-19 | E-GEOD-60761 | ArrayExpress
2013-12-09 | E-GEOD-51283 | ArrayExpress
2008-06-15 | E-GEOD-7798 | ArrayExpress
2015-02-23 | E-GEOD-59388 | ArrayExpress
2015-04-01 | E-GEOD-45656 | ArrayExpress
2012-08-18 | E-GEOD-37219 | ArrayExpress
2013-07-10 | E-GEOD-48629 | ArrayExpress
2014-06-02 | E-GEOD-58146 | ArrayExpress
2007-06-06 | E-TABM-212 | ArrayExpress